Home › Funds › BlackRock Inc › ADPT
BlackRock Inc position in ADPT
ADAPTIVE BIOTECHNOLOGIES COR · Health Care
Latest position (Q2 2026)15.14M sh
Reported value held$324.73M
Portfolio Weight0.01%
First reportedQ3 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 11.93M | $61.10M | New |
| Q4 2024 | 12.12M | $72.66M | Add |
| Q1 2025 | 12.23M | $90.87M | Add |
| Q2 2025 | 13.67M | $159.22M | Add |
| Q3 2025 | 13.36M | $199.84M | Reduce |
| Q4 2025 | 13.33M | $216.54M | Hold |
| Q1 2026 | 13.30M | $184.65M | Hold |
| Q2 2026 | 15.14M | $324.73M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ADPT
- Viking Global Investors 29.99M sh · $643.37M · Q2 2026
- Vanguard Group 11.28M sh · $183.22M · Q4 2025
- Wellington Management Group 5.91M sh · $126.80M · Q2 2026
- D. E. Shaw & Co 4.63M sh · $99.22M · Q2 2026
- Geode Capital Management 3.64M sh · $78.13M · Q2 2026
- UBS Group AG 3.13M sh · $67.15M · Q2 2026
- Invesco Ltd 3.09M sh · $66.37M · Q2 2026
- Goldman Sachs Group 2.98M sh · $64.01M · Q2 2026
- Arrowstreet Capital 2.52M sh · $54.15M · Q2 2026
- ARK Invest 2.09M sh · $44.84M · Q2 2026
- Bank of America Corp 1.73M sh · $37.11M · Q2 2026